戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 eptide and its partially trimmed products by exoglycosidases.
2 the N-glycopeptide pentasaccharide core with exoglycosidases.
3  trait that may be shared by other lysosomal exoglycosidases.
4 the glycoconjugate substrate by pneumococcal exoglycosidases.
5 ed glycopeptides were digested stepwise with exoglycosidases.
6                                        Three exoglycosidases, a neuraminidase (NanA), beta-galactosid
7    Brachypodium distachyon has a full set of exoglycosidases active on xyloglucan, including alpha-xy
8                     The absence of bacterial exoglycosidase activities and paucimannosidic N-glycans
9 mer turnover is PARG, which possesses mainly exoglycosidase activity but can remove olig(ADP-ribose)
10 anced by treatment of the G protein with the exoglycosidase alpha-mannosidase and reduced after subse
11 otal oligosaccharide pool using MALDI/MS and exoglycosidase analysis revealed 24 lactosamine species
12 ation of singular oligosaccharides to define exoglycosidase and glycosyl transferase branch specifici
13 e of oligosaccharides is to digest them with exoglycosidases and analyze the resulting digestion prod
14           Digestion of the glycopeptide by a exoglycosidase array and subsequent mass spectrometric a
15 e and linkage information, were confirmed by exoglycosidase array digestions of aliquots of the N-gly
16  may then be sequenced simultaneously, using exoglycosidase arrays.
17 butions of the endoglycosidase HYAL1 and the exoglycosidase beta-hexosaminidase to the lysosomal degr
18 onjunction with two other surface-associated exoglycosidases, BgaA, a beta-galactosidase, and StrH, a
19       By validating the identifications with exoglycosidase cocktails and MS/MS fragmentation, we det
20             Because manual interpretation of exoglycosidase data is complex and time consuming, we de
21                 However, we propose that the exoglycosidase-dependent liberation of monosaccharides f
22 ttern matches N-glycan peak shifts following exoglycosidase digestion and automates structure assignm
23                            Here we have used exoglycosidase digestion and mass spectrometry to sequen
24 ogonal and complementary techniques, such as exoglycosidase digestion arrays, analytical/preparative
25 specific enzymes are also routinely used for exoglycosidase digestion based carbohydrate sequencing.
26 sted to the proper pH can replace the normal exoglycosidase digestion buffers.
27                                              Exoglycosidase digestion coupled with matrix-assisted la
28 of the detected O-glycans were identified by exoglycosidase digestion facilitated with tandem mass sp
29 lysis, mild methanolysis, immunoblotting and exoglycosidase digestion indicated that the majority of
30                                        Using exoglycosidase digestion of the pSTf glycan, we demonstr
31                                           In exoglycosidase digestion studies, treatment with sialida
32                                        Using exoglycosidase digestion studies, we have now determined
33 ly characterized 25 O-glycan structures with exoglycosidase digestion to create a library with their
34                                              Exoglycosidase digestion was used to identify the indivi
35      In combination with HPLC fractionation, exoglycosidase digestion, and fragmentation of the glyca
36 y multidimensional mass spectrometry, and by exoglycosidase digestion, revealing a predominance of hi
37 in severe COVID-19 patients and modulated by exoglycosidase digestion.
38 a(1-6) arms) were separated and confirmed by exoglycosidase digestion.
39 ass spectrometry (MS/MS) in combination with exoglycosidase digestion.
40 ESI-MS and -MS/CID-MS, linkage analysis, and exoglycosidase digestion.
41                                   Sequential exoglycosidase digestions of IgA1 allowed identification
42                                              Exoglycosidase digestions of the glycopeptide from norma
43    We demonstrate new conditions that permit exoglycosidase digestions to be performed on the MALDI t
44 ion/ionisation (MALDI) mass spectrometry and exoglycosidase digestions to dissect the detailed struct
45 utoGU) that progressively analyzes data from exoglycosidase digestions to produce a refined list of f
46                                      Through exoglycosidase digestions we determined that the O-linke
47 njunction with mass composition analysis and exoglycosidase digestions), Edman degradation, and monos
48         Based on substrate analogue studies, exoglycosidase digestions, and co-chromatography with fu
49 cterized using database mining (GlycoStore), exoglycosidase digestions, and liquid chromatography-mas
50 fied by a combination of endoglycosidase and exoglycosidase digestions, anion-exchange chromatography
51 HPLC peak and, when used in combination with exoglycosidase digestions, progressively assigns each st
52 ce liquid chromatography (HPLC) coupled with exoglycosidase digestions.
53 ructures together with predicted products of exoglycosidase digestions.
54 somers were identified and confirmed through exoglycosidase digestions.
55    Native virus deglycosylation by endo- and exoglycosidases dramatically reduced cytokine production
56 enhance the stability and performance of the exoglycosidase enzyme neuraminidase and are used to crea
57     The following treatment with an array of exoglycosidase enzymes enables sequencing and a linkage-
58 te sequencing approach using the appropriate exoglycosidase enzymes in conjunction with the utilizati
59 s also utilized for accurate delivery of the exoglycosidase enzymes.
60  of N-glycan structures can be derived using exoglycosidases, enzymes that remove specific monosaccha
61 ate residues from exposure and hydrolysis by exoglycosidases (galactosidase and hexosaminidase).
62 that SpxR also positively regulates the strH exoglycosidase gene, which, like spxB, has been implicat
63 heir own or combined with mutations in other exoglycosidase genes, resulted in the accumulation of pa
64 okes the activity of both hyaluronidases and exoglycosidases has been advanced.
65 hanges in lectin binding upon treatment with exoglycosidases identified the primary specificities and
66 catalyzed by the concerted action of several exoglycosidases, including a broad specificity lysosomal
67 eatment of active MR-Fc with combinations of exoglycosidases, including neuraminidase and galactosida
68 m mass spectrometry, structure homology, and exoglycosidases is described that allows the structural
69 hat a combination of soft fragmentation with exoglycosidases is efficient at the assignment and quant
70 action was further digested with an array of exoglycosidase mixtures, and subsequent MALDI TOF MS ana
71               Despite these findings, triple exoglycosidase mutants colonized mice as well as their p
72 ry cleavage of terminal glycan residues with exoglycosidases offers a number of advantages over bench
73 eptococcal pathogens have evolved to express exoglycosidases, one of which is BgaC beta-galactosidase
74 try before and after treatment with endo- or exoglycosidases or with alkaline phosphatase.
75                                         Five exoglycosidases participate in xyloglucan hydrolysis in
76 ments with combinations of exosulfatases and exoglycosidases permits the selective removal of specifi
77 phy-mass spectrometry combined with specific exoglycosidase reactions to determine the sequences of N
78 eriments using human serum showed that these exoglycosidases reduced deposition of complement compone
79                                              Exoglycosidase removal of monosaccharides results in sig
80 ing that overexpression could not bypass the exoglycosidase restriction.
81 ntly, we show that many of the commonly used exoglycosidases retain both their activity and their spe
82 embryos, mass spectrometry fragmentation and exoglycosidase sensitivity defined a novel glucuronyl tr
83 d by lectin binding, saccharide composition, exoglycosidase sensitivity, and NMR spectroscopy.
84 ser-desorption ionisation mass spectrometry, exoglycosidase sequencing combined with normal-phase HPL
85                       Taken together, native exoglycosidase sequencing mass spectrometry (NES-MS) not
86                                    By use of exoglycosidase sequencing, in conjunction with high-perf
87 t joins native mass spectrometry with glycan exoglycosidase sequencing, the combination of which prov
88 ular domains of the protein using sequential exoglycosidase sequencing.
89 he complete structures were obtained through exoglycosidase sequencing.
90  (alpha-NAGAL; E.C. 3.2.1.49) is a lysosomal exoglycosidase that cleaves terminal alpha-N-acetylgalac
91               Alpha-L-fucosidase (ALF) is an exoglycosidase that is involved in the hydrolytic degrad
92 onas manihotis is known as a highly specific exoglycosidase that removes unbranched alpha1-6 linked m
93     Xyloglucan can be degraded by a suite of exoglycosidases that remove specific sugars.
94 on, GlycanAnalyzer enables the easier use of exoglycosidases to precisely define N-glycan structure.
95 ide standards were digested with one or more exoglycosidases to show that the enzymes retain their ac
96  in small microarrays (2.2 mm x 2.2 mm) with exoglycosidases to successively expose underlying featur
97 E- and PAE-generated fragments of native and exoglycosidase-treated blood-derived CBG of healthy indi
98               This processing was lost after exoglycosidase treatment and after RNAi-based silencing
99 ycosidase F treatment, lectin pulldowns, and exoglycosidase treatment, we have now investigated TfR N
100 dated by LC/MS analysis following sequential exoglycosidase treatments of the endoproteinase Lys-C di
101 defined GBPs and antibodies before and after exoglycosidase treatments on the microarray.
102 bardment (FAB) mass spectrometry, sequential exoglycosidase treatments, methylation analysis, and (1)
103 highly sensitive LC-MS/MS, MALDI-TOF-MS, and exoglycosidase treatments.
104 e glycan antennae were shortened by stepwise exoglycosidase treatments; this trend was consistent reg
105  of sugar residues from the terminal ends by exoglycosidases, up to 50% of total carbohydrates, did n
106                            By using specific exoglycosidases, we demonstrated that the SBA binding pr
107                             In this way, the exoglycosidases were more effectively used, and their us
108  related glycoforms did not occur naturally, exoglycosidases were used to achieve stepwise removal of
109                                              Exoglycosidases were used to remove terminally-exposed N

 
Page Top